Approval · Notice of Compliance 10496 · 2009
FLUDARA: Notice of Compliance 10496
Issued August 11, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10496
- Date
- August 11, 2009
- Company
- Genzyme Canada Inc
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antineoplastic
Products in this notice
Medicinal ingredients
- FLUDARABINE PHOSPHATE 10 MG per TAB
- FLUDARABINE PHOSPHATE SODIUM 50 MG per VIAL